UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5801
CALL
Lemonade
LMND
$4.1B
| $160K | ﹤0.01% |
+9,727
| New | +$162K |
|
|
RINC
5802
DELISTED
AXS Real Estate Income ETF
RINC
| $160K | ﹤0.01% |
+7,052
| New | +$161K |
|
5803
Conductor Global Equity Value ETF
CGV
$134M
| $160K | ﹤0.01% |
12,569
-3,207
| -20% | -$41.9K |
|
5804
Genesco
GCO
$422M
| $160K | ﹤0.01% |
6,189
-9,028
| -59% | -$236K |
|
5805
Principal Exchange-Traded Funds Principal US Mega-Cap ETF
USMC
$3.68B
| $160K | ﹤0.01% |
2,950
+1,550
| +111% | +$79.8K |
|
5806
CorMedix
CRMD
$584M
| $159K | ﹤0.01% |
36,819
-25,083
| -41% | -$127K |
|
5807
ASP Isotopes
ASPI
$558M
| $159K | ﹤0.01% |
+51,990
| New | +$201K |
|
5808
Aldeyra Therapeutics
ALDX
$93.5M
| $159K | ﹤0.01% |
48,026
-290
| -0.6% | -$1.14K |
|
|
EIC
5809
Eagle Point Income Co
EIC
$230M
| $159K | ﹤0.01% |
10,055
| – | – |
|
5810
FT Vest US Equity Moderate Buffer ETF August
GAUG
$292M
| $159K | ﹤0.01% |
4,718
+4,099
| +662% | +$136K |
|
|
AZUL
5811
PUT
DELISTED
Azul
AZUL
| $158K | ﹤0.01% |
+39,600
| New | +$232K |
|
|
KALV
5812
DELISTED
KalVista Pharmaceuticals
KALV
| $158K | ﹤0.01% |
13,406
-15,111
| -53% | -$176K |
|
5813
Ginkgo Bioworks
DNA
$521M
| $158K | ﹤0.01% |
11,815
-3,450
| -23% | -$103K |
|
|
FSCO
5814
FS Credit Opportunities Corp
FSCO
$1.02B
| $158K | ﹤0.01% |
24,751
-19,528
| -44% | -$120K |
|
|
WW
5815
DELISTED
WW International
WW
| $157K | ﹤0.01% |
134,601
-40,223
| -23% | -$66.9K |
|
5816
Applied Digital
APLD
$8.41B
| $157K | ﹤0.01% |
26,463
-62,347
| -70% | -$242K |
|
5817
Grupo Aeroportuario Centro Norte
OMAB
$5.33B
| $157K | ﹤0.01% |
2,326
-426
| -15% | -$33.9K |
|
5818
Research Frontiers
REFR
$17M
| $157K | ﹤0.01% |
85,400
+77,635
| +1,000% | +$136K |
|
|
BQ
5819
Boqii Holding Ltd
BQ
$6.33M
| $157K | ﹤0.01% |
29,810
+29,797
| +229,208% | +$110K |
|
5820
Establishment Labs
ESTA
$2.28B
| $157K | ﹤0.01% |
3,455
-833
| -19% | -$42.3K |
|
|
PSTX
5821
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $157K | ﹤0.01% |
53,623
-21,723
| -29% | -$59.4K |
|
5822
ClearPoint Neuro
CLPT
$433M
| $157K | ﹤0.01% |
29,047
-22,974
| -44% | -$133K |
|
|
GPMT
5823
Granite Point Mortgage Trust
GPMT
$61.2M
| $157K | ﹤0.01% |
52,707
-36,275
| -41% | -$134K |
|
5824
Trio Petroleum
TPET
$10.4M
| $156K | ﹤0.01% |
+25,815
| New | +$154K |
|
5825
AllianzIM US Equity 6 Month Floor5 Jan/Jul ETF
FLJJ
$8.6M
| $156K | ﹤0.01% |
5,809
+5,735
| +7,750% | +$151K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.